Answers are grounded in this paper and cite their sources.
To the Editor: Hypodermoclysis (subcutaneous administration of isotonic infusates) has proved to be efficient, safe, and cost-effective in treating mild to moderate dehydration in geriatrics.1,2 By contrast, there is a lack of information in the literature on the feasibility of infusing drugs through a subcutaneous route.3 Two cases of patients receiving palliative care in whom the oral route was unavailable and intravenous lines were difficult to maintain are reported. A 97-year-old woman with severe Alzheimer's disease (AD) suffered from a bleeding gastric ulcer and severe anemia. She had been hospitalized 2 months before because of hematemesis that resulted in six concentrated red blood cell transfusions. Severe gastric ulcers were identified using endoscopy, and proton pump inhibitor (PPI) (40 mg oral esomeprazole) treatment was started. Later, she was re-admitted to geriatrics because of anorexia, anemia, and abdominal pain. She was unable to swallow any food or drug, and intravenous lines were difficult to insert mainly because of behavioral problems. Recurrence of bleeding gastric ulcers was the most probable diagnosis. It was decided to infuse esomeprazole subcutaneously to reduce bleeding and pain. Esomeprazole (40 mg for intravenous injection diluted in 50 mL normal saline) was infused in 20 minutes at a dose of one-tenth of a vial (4 mg) on the first day, half of a vial (20 mg) on the second day, and then one vial (40 mg) per day. No significant adverse event such as skin intolerance was noted. She died after 10 days of treatment without any discomfort or gastric bleeding recurrence. An 85-year-old woman with severe AD was admitted to geriatrics because of behavioral disorders, mainly opposition and anorexia. Oral or intravenous drug administration was impossible. Three days after admittance, she suffered from hematemesis and anemia. It was estimated that digestive investigation would not be well tolerated, and the diagnosis of bleeding gastric ulcers was considered to be highly probable. It was decided to infuse esomeprazole subcutaneously to make her more comfortable as anemia seemed to worsen. The patient accepted and tolerated subcutaneous infusion of esomeprazole well for 13 consecutive days until she died. In this case, esomeprazole was reconstituted in 50 mL of normal saline and infused as a single daily dose (40 mg) for 1 hour. PPIs are particularly relevant in a palliative care setting when digestive investigations may not be appropriate. PPIs may be used in the case of uninvestigated hematemesis in patients in whom oral or intravenous routes are unavailable. Alternative strategies to intravenous administration of PPIs have been proposed through a nasogastric tube4 or rectal administration,5 but none of them are easy to use in patients in a palliative setting or in patients with severe AD. Intramuscular ranitidine has been reported to increase gastric pH and to be safe,6 but it is not as effective as PPIs. Moreover, esomeprazole has demonstrated greater antisecretory activity than other PPIs.7 To the authors' knowledge, this is the first case report of well-tolerated esomeprazole administrations through subcutaneous infusion and the second report of subcutaneous PPI administration.8 Conflict of Interest: The editor in chief has reviewed the conflict of interest checklist provided by the authors and has determined that the authors have no financial or any other kind of personal conflicts with this paper. T. Constans: speaker's forum Nouvelles Dimensions en Gériatrie, Novartis (Diabetes and hypertension in elderly patients) January 8 and 9, 2009; speaker's forum Unités de Soins Alzheimer, Eisai-Pfizer (Prevention of weight loss in Alzheimer patients) June 21 and 22, 2007; Principal investigator of a clinical trial: Safety and efficacy of subcutaneous administration of Clinimix N9G15E in elderly patients at risk for malnutrition. Protocol Nr CSC/P01/07/Mu.F. EudraCT Nr 2007-006153-31. Author Contributions: Concept and design: T. Constans. Acquisition of subjects and data: T. Desmidt. Analysis and interpretation of data: T. Desmidt and T. Constans. Preparation of manuscript: T. Desmidt. Critical review and approval: T. Constans. Sponsor's Role: None.
No takes yet. Share an insight, caveat, or question.
Desmidt et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: